PeopleBio, Inc. (KOSDAQ:304840)
South Korea flag South Korea · Delayed Price · Currency is KRW
561.00
-9.00 (-1.58%)
At close: Jul 31, 2026

PeopleBio Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-15,369-15,714-10,913-16,035-14,303-4,697
Depreciation & Amortization
957.871,7471,6921,5651,282734.08
Loss (Gain) From Sale of Assets
-1.152.4---17.65-5.17
Asset Writedown & Restructuring Costs
5,9815,98163.62---
Loss (Gain) From Sale of Investments
-989.21-1,108392.52395.43--
Loss (Gain) on Equity Investments
294.63758.25988.33934.89835.96380.5
Provision & Write-off of Bad Debts
119.46100.8384.73---
Other Operating Activities
4,0622,157-1,58061.432,299-2,450
Change in Accounts Receivable
375.14647.4223.68-1,502-1,553179.63
Change in Inventory
673.67-304.97-564.74-1,877-214-156.09
Change in Accounts Payable
24.3242.04-104.56-156.63259.4-157.08
Change in Other Net Operating Assets
-1,111307.88-1,194331.87-2,563-661.94
Operating Cash Flow
-4,982-5,183-10,911-16,282-13,975-6,833
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-4,948-213.61-78.6-719.15-1,267-1,355
Sale of Property, Plant & Equipment
7272--33.2529
Cash Acquisitions
-6.75-6.75---25.73
Sale (Purchase) of Intangibles
-77.38-110.17-36.14-41.08-73.12-35.3
Investment in Securities
5,1335,536-578.292,967-10,300-2,415
Other Investing Activities
-14.2776.6918.83-890.9364.94-217.79
Investing Cash Flow
389.055,354-674.21,316-11,542-3,968

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
-110.9514,850--31,000
Long-Term Debt Repaid
--1,464-2,694-27,048-684.16-1,333
Net Debt Issued (Repaid)
508.86-1,35312,156-27,048-684.1629,667
Issuance of Common Stock
4,199--29,6061,03612,992
Repurchase of Common Stock
----26.02--
Other Financing Activities
---0-518.45-1.75691.99
Financing Cash Flow
4,708-1,35312,1562,014350.0843,351

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Miscellaneous Cash Flow Adjustments
---00--
Net Cash Flow
115.34-1,182570.56-12,952-25,16632,550

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-9,930-5,396-10,990-17,001-15,242-8,188
Free Cash Flow Growth
------
Free Cash Flow Margin
-258.81%-189.30%-434.27%-381.80%-342.91%-1418.84%
Free Cash Flow Per Share
-439.60-247.98-505.52-1025.76-1041.91-510.46
Levered Free Cash Flow
-10,657-2,761-56.87-28,889-13,3789,824
Unlevered Free Cash Flow
-8,276-1,074532.67-27,390-11,51610,532

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
557.18158.24184.05251.37206.88106.75
Cash Income Tax Paid
--2.44-22.45-16.0654.655.68
Change in Working Capital
-38.13892.35-1,639-3,204-4,070-795.47